Hm Payson & CO Charles River Laboratories International, Inc. Transaction History

Hm Payson & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $7,552 - $11,188	37 New	37 $7,000
Q1 2022 May 12, 2022	SELL	$255.51 - $362.11 $7,665 - $10,863	-30 Closed	0 $0
Q1 2021 Jun 15, 2021	SELL	$249.67 - $299.48 $7,240 - $8,684	-29 Reduced 49.15%	30 $9,000
Q4 2020 Mar 10, 2021	BUY	$222.0 - $252.62 $6,438 - $7,325	29 Added 96.67%	59 $15,000
Q3 2020 Dec 21, 2020	BUY	$175.56 - $226.45 $5,266 - $6,793	30 New	30 $7,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

Stay updated on Hm Payson & CO with notifications on news.